🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is the estimation of the human papillom...
Status
Completed
Location
Sotobo Children's Clinic ( Site 6616)
Start Date
2021-05-17
Trial ID
NCT04772534
Treatments Being Tested
This study will evaluate the efficacy, immunogenicity and safety of 9-valen...
Status
Active Not Recruiting
Location
Lingchuan Center for Disease Control and Prevention ( Site 0002)
Start Date
2019-06-26
Trial ID
NCT03998254
Researchers are looking for new ways to prevent cancers related to human pa...
Status
Active Not Recruiting
Location
Research Centers of America ( Hollywood ) ( Site 0001)
Start Date
2024-12-20
Trial ID
NCT06688058
Treatments Being Tested
Primary objective: • To demonstrate that administration of V503 induces no...
Status
Completed
Location
Multiple Locations
Start Date
2011-02-23
Trial ID
NCT01304498
Researchers are looking for new ways to prevent cancers related to human pa...
Status
Active Not Recruiting
Location
Anaheim Clinical Trials ( Site 0002)
Start Date
2024-11-12
Trial ID
NCT06623409
Treatments Being Tested
This study will evaluate the safety and immunogenicity of V503 (GARDASIL™9,...
Status
Completed
Location
National Institute of Hygiene and Epidemiology ( Site 0001)
Start Date
2018-06-29
Trial ID
NCT03546842
Treatments Being Tested
This study is designed to demonstrate non-inferior immunogenicity of 3 dose...
Status
Active Not Recruiting
Location
Liucheng County Centers for Disease Control and Prevention ( Site 0005)
Start Date
2022-05-07
Trial ID
NCT05314023
Treatments Being Tested
The purposes of this phase 3, double-blind, placebo-controlled clinical stu...
Status
Completed
Location
Umeyama Clinic ( Site 6406)
Start Date
2020-11-30
Trial ID
NCT04635423
This study will evaluate the immunogenicity and tolerability of V503 (a mul...
Status
Completed
Location
Multiple Locations
Start Date
2009-08-27
Trial ID
NCT00943722
Treatments Being Tested
This study will evaluate the tolerability and immunogenicity of administrat...
Status
Completed
Location
Multiple Locations
Start Date
2009-10-21
Trial ID
NCT00988884